Issue: May 2016
May 09, 2016
1 min read
Save

Trial Scorecard: CRUSH

Issue: May 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Trial evaluated whether crushing prasugrel tablets would improve absorption and platelet inhibition in patients with STEMI needing PCI.

Trial Scorecard: CRUSH